학술논문
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry
Document Type
Article
Author
Zhang, Junfen; Boesjes, Celeste M.; Loman, Laura; Kamphuis, Esmé; Romeijn, Margreet L.E.; Spekhorst, Lotte S.; Haeck, Inge; van der Gang, Lian F.; Dekkers, Coco C.; van der Rijst, Lisa P.; Oosting, Albert J.; van Lumig, Paula; van Lynden-van Nes, Anneke M.T.; Tupker, Ron A.; Nijssen, Annieke; Flinterman, Annebeth; Politiek, Klaziena; Touwslager, Wouter R.H.; Christoffers, Wianda A.; Stewart, Shiarra M.; Kamsteeg, Marijke; de Graaf, Marlies; de Bruin-Weller, Marjolein S.; Schuttelaar, Marie-Louise A.
Source
In Journal of the American Academy of Dermatology April 2024
Subject
Language
ISSN
0190-9622